Conditional VHL gene deletion activates a local NO-VEGF axis in a balanced manner reinforcing resistance to endothelium-targeted glomerulonephropathy

Nephrology Dialysis Transplantation

Volumn 26, Issue 12, 2011, Pages 4023-4031

  Morita, Taku ^a   Kakinuma, Yoshihiko ^a   Kurabayashi, Atsushi ^a   Fujieda, Mikiya ^a   Sato, Takayuki ^a   Shuin, Taro ^a   Furihata, Mutsuo ^a   Wakiguchi, Hiroshi ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Habu snake venom glomerulonephropathy; nitric oxide; vascular endothelial growth factor

Indexed keywords

CREATININE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYPOXIA INDUCIBLE FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SNAKE VENOM; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIUM CELL; GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENOTYPE; GLOMERULOPATHY; GLOMERULUS CAPILLARY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UPREGULATION; UREA BLOOD LEVEL; VHL GENE;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE DELETION; GLOMERULONEPHRITIS; HUMANS; MICE; NITRIC OXIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 82255181486     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr176     Document Type: Article

References (36)

1. Kudo Y, Kakinuma Y, Mori Y et al. Hypoxia-inducible factor-1alpha is involved in the attenuation of experimentally induced rat glomerulonephritis. Nephron Exp Nephrol 2005; 100: e95-e103 (Pubitemid 40868657)
2. Kudo Y, Kakinuma Y, Iguchi M et al.Modification in the von Hippel-Lindau protein is involved in the progression of experimentally induced rat glomerulonephritis. Nephron Exp Nephrol 2007; 106: e97-e106 (Pubitemid 47026178)
3. Iguchi M, Kakinuma Y, Kurabayashi A et al. Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney. Nephron Exp Nephrol 2008; 110: e82-e90
4. Richard D, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor-1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765-26771
5. Nakagawa T. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol 2007; 292: F1665-F1672 (Pubitemid 47105355)
6. Ma W, Tessarollo L, Hong S et al. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res 2003; 63: 5320-5328 (Pubitemid 37139846)
7. Kakinuma Y, Ando M, Kuwabara M et al. Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha. FEBS Lett 2005; 579: 2111-2118 (Pubitemid 40469679)
8. Cattell V, Bradfield J. Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom. A morphologic study. Am J Pathol 1977; 87: 511-524 (Pubitemid 8136783)
9. Haas C, Câmpean V, Kuhlmann A et al. Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis. Virchows Arch 2007; 450: 81-92 (Pubitemid 46360749)
10. Kuwabara M, Kakinuma Y, Ando M et al. Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis. J Physiol Sci 2006; 56: 95-101 (Pubitemid 46952772)
11. Park KM, Byun JY, Kramers C et al. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266 (Pubitemid 36876883)
12. Shin IC, Kim HC, Swanson J et al. Anxiolytic effects of acute morphine can be modulated by nitric oxide systems. Pharmacology 2003; 68: 183-189 (Pubitemid 36831225)
13. MaynardMA, OhhM. von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Am J Nephrol 2004; 24: 1-13
14. Abe-Yoshio Y, Abe K, Miyazaki M et al. Involvement of bone marrow-derived endothelial progenitor cells in glomerular capillary repair in habu snake venom-induced glomerulonephritis. Virchows Arch 2008; 453: 97-106
15. Iruela-Arispe L, Gordon K, Hugo C et al. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 1995; 147: 1715-1727
16. Kelly D, Hepper C, Wu L et al. Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model. Nephrol Dial Transplant 2003; 18: 1286-1292 (Pubitemid 36826947)
17. Kang D, Yu E, Yoon K et al. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 2004; 164: 679-688 (Pubitemid 38364681)
18. Kang D, Hughes J, Mazzali M et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001; 12: 1448-1457 (Pubitemid 32666327)
19. Cooper M, Vranes D, Youssef S et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999; 48: 2229-2239 (Pubitemid 29521855)
20. de Vriese A, Tilton R, Elger M et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001; 12: 993-1000 (Pubitemid 32378340)
21. Masuda Y, Shimizu A, Mori T et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001; 159: 599-608 (Pubitemid 32751090)
22. Zhao Q, Egashira K, Inoue S et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 2002; 105: 1110-1115 (Pubitemid 34212623)
23. Ziche M, Morbidelli L, Choudhuri R et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-2634 (Pubitemid 27259809)
24. Chander V, Chopra K. Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats. Arch Med Res 2006; 36: 19-26 (Pubitemid 41727886)
25. Ialenti A, Ianaro A, Maffa P et al. Nitric oxide inhibits leukocyte migration in carrageenin-induced rat pleurisy. Inflamm Res 2000; 49: 411-427
26. Cuzzocrea S, Chatterjee PK, Mazzon E et al. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 2002; 18: 169-176
27. Ho FM, Liu SH, Liau CS et al. Nitric oxide prevents apoptosis of human endothelial cells from high glucose exposure during early stage. J Cell Biochem 1999; 75: 258-263 (Pubitemid 29463494)
28. Kim HW, Greenburg AG. Nitric oxide scavenging, alone or with nitric oxide synthesis inhibition, modulates vascular hyporeactivity in rats with intraperitoneal sepsis. Shock 2002; 17: 423-426
29. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-1058 (Pubitemid 17154788)
30. Milsom A, Patel N, Mazzon E et al. Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemiareperfusion injury in mice. Nitric Oxide 2010; 22: 141-148
31. Kohno T, Mizukami H, Suzuki M et al. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGFproducing ovarian cancer. Cancer Res 2003; 63: 5091-5094 (Pubitemid 37022649)
32. Elenkov I, Chrousos G. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002; 966: 290-303 (Pubitemid 34729188)
33. Cattaruzza M, Słodowski W, Stojakovic M et al. Interleukin-10 induction of nitric-oxide synthase expression attenuates cd40-mediated interleukin-12 synthesis in human endothelial cells. J Biol Chem 2003; 278: 37874-37880 (Pubitemid 37175316)
34. Silvestre J, Mallat Z, Duriez M et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2000; 87: 448-452
35. Furuichi K, Wada T, Kitajima S et al. IFN-inducible protein 10 (CXCL10) regulates tubular cell proliferation in renal ischemiareperfusion injury. Nephron Exp Nephrol 2008; 109: c29-c38 (Pubitemid 351919490)
36. Bodnar R, Yates C, Rodgers M et al. IP-10 induces dissociation of newly formed blood vessels. J Cell Sci 2009; 122: 2064-2077